Minnesota Suit Against E-Cigarette Maker Juul Goes to Trial

March 28, 2023by Steve Karnowski, Associated Press
Minnesota Suit Against E-Cigarette Maker Juul Goes to Trial
A Juul electronic cigarette starter kit is seen at a smoke shop on Dec. 20, 2018, in New York. (AP Photo/Seth Wenig, File)

MINNEAPOLIS (AP) — Minnesota Attorney General Keith Ellison is slated to lead off opening statements expected for Tuesday in his state’s lawsuit against Juul Labs – marking the first time any of the thousands of cases against the e-cigarette maker over its alleged marketing to young people is going to play out in a courtroom.

Minnesota sued Juul in 2019, accusing the San Francisco-based company of unlawfully targeting young people with its products to get a new generation addicted to nicotine. Ellison has declined to put a dollar figure on how much money the state is seeking in damages and civil penalties. But he said when he announced the lawsuit that it could be in the ballpark with Minnesota’s landmark $7.1 billion settlement with the tobacco industry in 1998.

Juul has faced thousands of lawsuits nationwide but most have settled, including 39 with other states and U.S. territories. Minnesota added tobacco industry giant Altria, which formerly owned a minority stake in Juul, as a co-defendant in 2020. Altria completed its divestiture this month and says it effectively lost its $12.8 billion investment. A few days later, Altria announced a $2.75 billion investment in rival electronic cigarette startup NJOY.

“We will prove how Juul and Altria deceived and hooked a generation of Minnesota youth on their products, causing both great harm to the public and great expense to the State to remediate that harm,” Ellison said in a statement.

The jury trial, before Hennepin County District Judge Laurie Miller, is expected to last about three weeks. That contrasts with nearly four months for the landmark 1998 lawsuit by the state and Blue Cross and Blue Shield of Minnesota against the big tobacco companies.

That case forced the release of millions of pages of previously secret industry documents and ended in a $7.1 billion settlement just before the state was due to deliver its closing arguments. Part of the money went to fund anti-smoking programs, but both Juul and Altria have pointed out in court filings that lawmakers opted to spend much of the money simply to fund state government.

Ellison plans to deliver part of the state’s opening statement himself before handing it off to attorneys from two outside law firms that are handling the case for Minnesota. The lawsuit alleges consumer fraud, creating a public nuisance, unjust enrichment and conspiracy. A brief filed last week gave a preview of the state’s arguments.

“Defendant JUUL, in a conspiracy joined by Altria, preyed upon and enticed Minnesota’s children, through deceptive and illegal tactics, to buy a product that may sentence them to a lifetime of nicotine addiction and other destructive behaviors,” attorneys for the state wrote. “JUUL embarked on a design and marketing campaign that would ensnare children, focusing on attracting ‘cool kids,’ creating a nicotine ‘buzz,’ and using social media and celebrities to act as ‘pushers’ of its addictive products. Defendants claim their conduct was in the name of helping ‘aging smokers’ to stop smoking. That claim is false; it is a smoke screen.”

Juul said in a statement that Minnesota had rejected settlement offers similar to those it reached with other states, which provided “hundreds of millions of dollars to further combat underage use and develop cessation programs in those states.”

“Effective interventions to address underage use of all tobacco products in Minnesota, including vapor, depends not on headline-driven trials, but on evidence-based policies, programs, and enforcement,” the statement continued. “This is the approach that Juul Labs supports and has been part of implementing.”

Altria Group — the maker of Marlboro cigarettes and other tobacco products formerly known as Phillip Morris Cos. — is minimizing its role. It said in a court filing last week that it bought a 35% stake in Juul Labs in 2018 after its own vaping products failed to gain traction, and only after Juul assured Altria “and announced to the world,” that it had made “meaningful changes” to its marketing practices.

Richmond, Virginia-based Altria said the services it provided to Juul — supplying strategic counter space in stores and distributing a Juul ad and coupons to adult smokers — lasted just over a year and ended in March 2020 And it maintains that its support did not appreciably increase sales of Juul products in Minnesota nor the use of e-cigarettes by minors in the state.

Juul, which launched in 2015, became the U.S. vaping market leader on the popularity of flavors like mango, mint and creme brulee. Its rise was fueled by its use among teenagers, some of whom became hooked on Juul’s high-nicotine pods. Amid the backlash, Juul dropped all U.S. advertising and discontinued most of its flavors in 2019. Juul has since lost popularity with teens, and its share of the multibillion-dollar market has fallen to about 33% from a high of 75%.

In June, the Food and Drug Administration rejected Juul’s application to keep its products on the market as a smoking alternative for adults, though that decision is on appeal. In September, Juul agreed to pay nearly $440 million to settle a two-year investigation by 33 states into its marketing of high-nicotine products.

States with litigation still pending against Juul include New York, California, Massachusetts, New Mexico, Alaska, Illinois and West Virginia, plus the District of Columbia.

A+
a-
  • FDA
  • smoking
  • In The News

    Health

    Voting

    Health

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

    Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

    April 16, 2024
    by Dan McCue
    Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

    Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

    Are Americans Feeling Like They Get Enough Sleep? Dream On, a New Gallup Poll Says

    NEW YORK (AP) — If you're feeling — YAWN — sleepy or tired while you read this and wish you... Read More

    NEW YORK (AP) — If you're feeling — YAWN — sleepy or tired while you read this and wish you could get some more shut-eye, you're not alone. A majority of Americans say they would feel better if they could have more sleep, according to a... Read More

    News From The Well
    scroll top